202202065445/Scientific Research Program of Hunan Provincial Health Commission[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

TIAM2 Contributes to Osimertinib Resistance, Cell Motility, and Tumor-Associated Macrophage M2-like Polarization in Lung Adenocarcinoma.

Liang L, He H, Jiang S, Liu Y, Huang J, Sun X, Li Y, Jiang Y, Cong L. Liang L, et al. Int J Mol Sci. 2022 Sep 8;23(18):10415. doi: 10.3390/ijms231810415. Int J Mol Sci. 2022. PMID: 36142328 Free PMC article.

NCAPG2 Maintains Cancer Stemness and Promotes Erlotinib Resistance in Lung Adenocarcinoma.

Jiang S, Huang J, He H, Liu Y, Liang L, Sun X, Li Y, Cong L, Qing B, Jiang Y. Jiang S, et al. Cancers (Basel). 2022 Sep 9;14(18):4395. doi: 10.3390/cancers14184395. Cancers (Basel). 2022. PMID: 36139554 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2 results

Search Page

Filters